Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02134184 · ClinicalTrials.gov registry record · Phase 4
The Influence of Chronic CMV Infection on Influenza Vaccine Responses
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
NCT02134184: Completed Phase 4 study, sponsored by Stanford University.
NCT02134184 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02134184, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
Study Summary
In this study we are trying to understand whether previous infection with a particular virus, namely cytomegalovirus (CMV), influences the ability of the immune system to respond to new infections or vaccinations with age.
Interventions
- BIOLOGICAL Fluzone® 2012-2013 Formula NDC No 498281-012-50
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02134184
The ClinicalTrials.gov registry entry for NCT02134184 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluzone® 2012-2013 Formula NDC No 498281-012-50 is the first listed.
NCT02134184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02134184 about?
NCT02134184 is a clinical study titled "The Influence of Chronic CMV Infection on Influenza Vaccine Responses". In this study we are trying to understand whether previous infection with a particular virus, namely cytomegalovirus (CMV), influences the ability of the immune system to respond to new infections or vaccinations with age.
What is the current status of trial NCT02134184?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2012-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT02134184?
The interventions under investigation include: Fluzone® 2012-2013 Formula NDC No 498281-012-50 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02134184?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.